ERNA vs ROL · P/E 0.0, rev $582.0K vs P/E 41, rev $3.39B
Eterna Therapeutics Inc (ERNA) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the ERNA and ROL stock pages for the full models.
Not investment advice.